by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Mar 12, 2014 | Drug Prices, Healthcare Reform, Medicare Drug Plans
Last week, we reported on proposed changes to Medicare Part D that could have made it harder for millions of seniors to obtain prescribed medicine. One congressman from Pennslvania, Tim Murphy, went so far to say that suicide rates would increase as a result of the proposed changes, referring to a change that would have allowed insurers to reduce coverage for antipsychotics, immunosuppressants, and antidepressants. Other proposed changes included allowing the government to intervene in contracts between insurers and pharmacies, limiting the number of drug plans available, and also expanding access to community pharmacies.
Outcry from both sides of the aisle, as well as patient and consumer rights advocates, has resulted in the Obama administration reversing course on the changes. “We will engage in further stakeholder input before advancing some or all of the changes in these areas in future years,” wrote Marilyn Tavenner, Administrator of the Centers for Medicare and Medicaid Services.
We are glad specifically that coverage for critical medication will remain strong and that the number of drug plans will not be limited in certain areas. We know that the intention of reducing drug plans was to help make it easier to choose a plan. On the other hand, we support expanding access to community pharmacies and hope for further action on that front.
Fortunately, there are online resources that can help with this. Not all Medicare drug plans are created equal. PharmacyChecker.com runs MedicareDrugPlans.com, which you can use to compare plans and read or write reviews on those plans available in your area.
Tagged with: Marilyn Tavenner, Medicare Part D, medicaredrugplans.com, Tim Murphy
by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Mar 6, 2014 | Drug Prices, Healthcare Reform, Medicare Drug Plans
Future Changes to Medicare Part D may curtail access to affordable medication for millions of seniors enrolled in Part D prescription drug plans, according to Kaiser Health News and USA Today.
The Obama administration wants to remove three drug classes, immunosuppressants, antipsychotics, and antidepressants, from the list of specially protected drugs. What this means is that insurers would no longer be required to cover the majority of these drugs in those classes. What that means is that more patients will struggle to afford – and even skip – medications due to high out-of-pocket costs at U.S. pharmacies.
An alliance of Democrats, Republicans, drug companies, and patient advocates oppose the proposal. Rep. Tim Murphy, R-PA, who is also a psychologist, fears the worst: “If you restrict access to these drugs you restrict the treatment of mental illness,” he said. “You raise suicide rates.” Murphy’s sharp statement suggests just how important drug coverage for Medicare beneficiaries is. Over half of seniors aged 65 or older take at least five prescription drugs, and a carefully organized prescription plan may have disastrous side-effects if a drug is switched for another. Such substitution would likely occur for many patients if drugs are removed from special protection. (more…)
Tagged with: Medicare Part D, Tim Murphy
by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Feb 28, 2014 | Advocacy, Drug Prices
Testifying before Congress was the last place I expected to see Seth Rogen, star of movies Superbad and Knocked Up. But there he was, in front of the Senate Appropriations Subcommittee on Labor, Health and Human Services, speaking about his family’s experience with Alzheimer’s disease in order to raise awareness about its effects, including the high costs of treatment.
Although there is no known cure for Alzheimer’s or its progression, there is medication that can help alleviate symptoms, such as memory loss and confusion. Rogen points out that he can’t imagine how patients on limited incomes treat Alzheimer’s and that it is the most “costly condition in the United States…where in a country for a dollar and twenty-nine cents you can get a taco made out of Doritos.” We thought it would be helpful to show how much Americans can save on Alzheimer’s medication by ordering from a verified international online pharmacy. Looking at one brand name and two generic medications, we found an average savings of 72%.
Savings on 3-month Supplies of Alzheimer’s Medication
U.S. Pharmacy Price from Rite-Aid in New York City. International Online Pharmacy Price taken from PharmacyChecker.com.
*Price calculated from 90 pills
+Price calculated from 100 pills
Tagged with: Alzheimer's Disease, Appropriations, Congress, Seth Rogen
by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Feb 20, 2014 | Drug Prices, Pharmaceutical Industry
As recently reported by PBS, America continues to outspend other rich countries on pharmaceuticals, spending almost $1,000 per person on prescription drugs in 2013. Canada, the second highest spender, spent about $700 per person. This is despite one in five Americans skipping doses or a script due to cost, as well as an extremely high percentage (84% in 2011) of prescriptions being written for generic medications.
So what’s up? Well, for one, our drug prices are much higher. Our latest analysis of brand-name drugs sold by international online pharmacies found that their prices were 88% lower when compared to a pharmacy in New York City.
Major drug price differences aren’t the only reason for higher U.S. spending. PBS explains that Americans, sadly, fill more scripts due to higher rates of obesity, diabetes, and high blood pressure, which of course equates with greater numbers of prescription drug purchases. Another factor is that it’s relatively easy for drug companies to get new drugs approved and in to the U.S. market.
I was a bit surprised that PBS didn’t mention direct-to-consumer advertising as a possible reason for why we use more drugs. New Zealand is the only other country that allows direct-to-consumer advertising, but they have much lower drug prices than the U.S., due to government regulations.
For the newly insured, Obamacare might mean lower prices for consumers, but that doesn’t mean overall national spending will go down. Lower out of pocket costs from better co-pay or co-insurance models will likely just mean higher premiums and increased reimbursement to drug manufacturers by insurance companies. Look at it this way: if you spend $20 less on a drug per month, but your premium is $20 more, you’re not really any better off.
Interestingly, U.S. drug spending decreased slightly last year, thanks largely to patent expirations resulting in more generic drugs penetrating the market. While PBS mentions that the decline is expected to last another 2-3 years, I’m not so optimistic. For one, generic drug prices are rising, sometimes by thousands of percent. Second, more coverage under Obamacare means more prescriptions, and naturally more spending. Only time will tell…
Tagged with: drug spending, Obamacare, PBS
by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Feb 13, 2014 | Drug Importation, FDA, Online Pharmacies
(Click here to skip the explanations and view the steps to finding a Canadian online pharmacy)
If you’ve seen one of the latest FDA press releases regarding Canadian pharmacies, you might be a little confused on how to find one. The FDA seems to acknowledge that there are legitimate – and therefore safe – Canadian pharmacies accessible online. Here’s what they say (with one word italicized by us):
“Don’t order medicines from web sites that claim to be Canadian pharmacies. Most are not legitimate pharmacies, and the drugs they supply are illegal and potentially dangerous.
Claiming to be a Canadian pharmacy is one of the hallmarks of Internet sites that sell illegal prescription drugs which, in many cases, are not made in Canada at all, but in a number of other countries. (Even if an online Canadian pharmacy is legitimate, in general, U.S. citizens cannot legally import prescription drugs from other countries. But that’s a separate issue. We’re talking here about fraud).”
The FDA’s focus on protecting you from online pharmacy fraud is commendable because that’s where the real health and safety threats reside. Since they don’t tell you how to find a legitimate, real Canadian pharmacy, we’re providing you with facts and guidance to help you make the right decisions for your health and prescription savings. Let’s remember, brand name medications sold in Canada and other non-U.S. pharmacies are often astronomically cheaper than ones here at home. (more…)
Tagged with: Canadian pharmacies, FDA, NABP, phrma
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Feb 7, 2014 | Drug Importation, Drug Prices
Let’s give a big round of applause to CVS, the second largest chain pharmacy (behind Walgreens), for its decision to stop selling cigarettes and other tobacco products! To its credit, CVS is not being overly self-righteous, as it largely attributes the policy change as necessary to accommodate legal restrictions on tobacco sales in places where healthcare services are provided: this is in view of its plans to open up more healthcare clinics in its pharmacies throughout the country. So, come October, as per the company’s plans press release, Americans will no longer be able to buy cigarettes or other tobacco products at any of the 7,000-plus CVS stores nationwide.
Unfortunately, removing tobacco products from CVS’ shelves won’t help Americans afford their medicine. According to a survey by Consumer Reports, CVS has the highest drug prices (Costco had the lowest prices, especially on generics). While executives at U.S. pharmacy corporations have steadfastly opposed reforming drug importation laws to bring down drug costs, CVS’ former Chairman and CEO, Thomas Ryan, bravely supported it. To quote Mr. Ryan:
While many in our industry believe that importation is a fundamentally flawed concept and oppose it without exception, I have come to a slightly different view…Millions of Americans already have opted to import drugs because they can’t afford not to. We owe it to them to face this issue head on and not look the other way.
That statement was provided by Mr. Ryan in 2004. Since that time, access to affordable medication in the U.S. has only become more difficult due to higher drug prices, and Americans continue to personally import their medication, often from international online pharmacies.
The reason that those online pharmacies are a lifeline is provided by none other than…CVS! CVS/Caremark surveyed their pharmacists about a year ago; 61% cited high drug costs as the number one reason Americans don’t take their meds. Canadian and other foreign pharmacies have much lower prices and so Americans need them.
To be intellectually honest, Mr. Ryan’s idea was not for Americans to buy directly from Canadian or other foreign pharmacies but for CVS to import less expensive medication from verified foreign wholesale pharmacies and then sell it to Americans. Not a bad idea to help bring down drug costs, while keeping American pharmacists employed and corporate profits humming. Thus, understandably, Mr. Ryan’s position was dedicated to the public health and his business interests.
The heart and soul of Mr. Ryan’s position, however, is the public health alone – and not business interests. Once again, he said: “Millions of Americans already have opted to import drugs because they can’t afford not to. We owe it to them to face this issue head on and not look the other way.” They opt to import because brand name drugs are often 90% less expensive internationally. That’s why it’s best to help Americans safely buy medications where they can best afford it instead of looking the other way.
So you can put out that cigarette, get your flu shots from CVS, your generics from Costco and your brand name drugs overseas!
Tagged with: Consumer Reports, CVS, Tobacco
